Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ahead, Anhui, argued, argument, cap, certiorari, childcare, collapsed, combat, commonly, comparison, CRO, Department, difficulty, dollar, entirety, fluidity, GLP, hasten, HHS, hVIVO, Kingdom, Lagevrio, Longcom, main, Melbourne, molpiravir, newly, nirmatrelvir, nonmonetary, ORPH, Orphan, Paxlovid, pervasive, PK, plc, prepaid, provincial, ratio, recalculated, refundable, registry, Relenza, remeasured, remeasurement, retail, ritonavir, Serum, specialist, steam, Stipulation, tasked, Vaxart, vein, writ, WTO, Zhifei
Removed:
affiliated, aggressively, AGP, analyst, attached, blend, Bulletin, child, Chimerix, combined, comparing, convert, conveyance, coupon, delist, delisted, digit, Gary, Georgia, GlaxoSmithKline, improvement, irrespective, led, Ligocyte, merged, MusclePharm, Nevada, nonemployee, overseeing, placement, promised, pronouncement, refer, reincorporated, remote, secured, shareholder, Southern, stringent, surface, surged, surviving, underwriter, warranted, Wilcox, York
Filing tables
Filing exhibits
COCP similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Cocrystal Pharma, Inc.
Bothell, Washington
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-231022 and No. 333-237738) and on Form S-8 (No. 333-193161 and No. 333-224869) of Cocrystal Pharma, Inc. of our report dated March 29, 2023, relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K.
/s/ Weinberg & Company | |
Los Angeles, California | |
March 29, 2023 |